cis,trans-2,5-Dimethyltetrahydrothiophen-S-oxid | 446876-22-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 噻烷
• 英文名称: cis,trans-2,5-Dimethyltetrahydrothiophen-S-oxid
• 英文别名: 2,5-dimethyl-tetrahydro-thiophene-1-oxide；2,5-Dimethyl-tetrahydro-thiophen-1-oxid；2,5-Dimethyl-sulfolane；2,5-dimethylthiolane 1-oxide
• CAS: 446876-22-8
• 化学式: C₆H₁₂OS
• 分子量: 132.227
• InChiKey: VHQWJCUFWZLZLL-UHFFFAOYSA-N

物化性质

• 沸点：
  258.3±7.0 °C(Predicted)
• 密度：
  1.09±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  36.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 硝酸 作用下， 生成 cis,trans-2,5-Dimethyltetrahydrothiophen-S-oxid
  参考文献：
  名称：

  Grischkewitsch-Trochimowski, Zhurnal Russkago Fiziko-Khimicheskago Obshchestva, 1916, vol. 48, p. 920

  摘要：

  DOI：

文献信息

• Photoacid generators, chemically amplified resist compositions, and patterning process
  申请人：——

  公开号：US20040229162A1

  公开（公告）日：2004-11-18

  Photoacid generators have formula (1) wherein R 1 and R 2 are alkyl, or R 1 and R 2 , taken together, may form a C 4 -C 6 ring structure with sulfur, R is hydrogen or alkyl, R′ is hydrogen, alkyl, alkoxyl or nitro, n is 1 to 6, and Y − is alkylsulfonate, arylsulfonate, bisalkylsulfonylimide or trisalkylsulfonylmethide. Chemically amplified resist compositions comprising the same have improved resolution, thermal stability, storage stability and minimized line edge roughness. 1

  光酸发生剂的化学式为（1），其中R1和R2是烷基，或者R1和R2结合在一起，可以形成带有硫的C4-C6环结构，R为氢或烷基，R'为氢、烷基、烷氧基或硝基，n为1至6，Y-为烷基磺酸盐、芳基磺酸盐、双烷基磺酰亚胺或三烷基磺酰甲基。包含上述光酸发生剂的化学增感型光阻组合物具有更好的分辨率、热稳定性、储存稳定性和最小化线边粗糙度。
• SUBSTITUTED 4-ALKOXYPICOLINAMIDE ANALOGS AS MGLUR5 NEGATIVE ALLOSTERIC MODULATORS AND METHODS OF MAKING AND USING THE SAME
  申请人：VANDERBILT UNIVERSITY

  公开号：US20170247366A1

  公开（公告）日：2017-08-31

  Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
• US7235343B2
  申请人：——

  公开号：US7235343B2

  公开（公告）日：2007-06-26